hrp0098p1-212 | Adrenals and HPA Axis 3 | ESPE2024

Negative Impact of Supraphysiological Glucocorticoid Dosing on Growth and Changes in Glucocorticoid Dose and Androstenedione Health States in Patients with Classic Congenital Adrenal Hyperplasia: Results from the CAHtalog™ Patient Registry

Lekarev Oksana , Sen Ginny , Haider Mahroz , Tang Fei , Friedler Haley , Chen Joy , Lin-Su Karen , Matos Dina , Dessibourg Jackie , Cheng Henry , Roberts Eiry , Chan Jean , Jeha George

Introduction: Patients with classic congenital adrenal hyperplasia (CAH) require glucocorticoid (GC) therapy to replace cortisol insufficiency and reduce excess adrenal androgens, usually necessitating supraphysiologic GC doses. CAHtalog™, developed in partnership with CARES Foundation using the PicnicHealth platform, is a real-world US patient registry that characterizes the natural history of classic CAH. This study explored changes in health states ba...